Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Disease Progression"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 179263
Tytuł:
Predicting onset of disease progression using temporal disease occurrence networks.
Autorzy:
Choudhary GI; School of Computing, University of Eastern Finland. Electronic address: .
Fränti P; School of Computing, University of Eastern Finland. Electronic address: .
Pokaż więcej
Źródło:
International journal of medical informatics [Int J Med Inform] 2023 Jul; Vol. 175, pp. 105068. Date of Electronic Publication: 2023 Apr 11.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Disease Progression*
Humans ; Male ; Female ; Risk Factors
Czasopismo naukowe
Szczegóły
Tytuł:
Peeling the I-Onion to Demystify Pseudoprogression.
Autorzy:
Tsang ES; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address: .
Siu LL; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2023 Sep 11; Vol. 41 (9), pp. 1545-1547.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Neoplasms*/drug therapy
Disease Progression*
Humans
Czasopismo naukowe
Szczegóły
Tytuł:
Long-term clinical course of Heyn-Sproul-Jackson syndrome.
Autorzy:
Futagawa H; Department of Clinical Genetics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Ito S; Department of Nursing, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Kosaki K; Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.
Yoshihashi H; Department of Clinical Genetics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Pokaż więcej
Źródło:
Congenital anomalies [Congenit Anom (Kyoto)] 2023 Sep; Vol. 63 (5), pp. 174-175. Date of Electronic Publication: 2023 Jul 30.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Disease Progression*
Fetal Growth Retardation*
Microcephaly*
Developmental Disabilities*
Humans ; Syndrome
Czasopismo naukowe
Szczegóły
Tytuł:
Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.
Autorzy:
Johann PD; Paediatric and Adolescent Medicine, Swabian Children's Cancer Center Augsburg, EU-RHAB Trial Center, Germany and Bavarian Cancer Research Center (BZKF), Augsburg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Research Consortium (DKTK), Heidelberg, Germany.
Altendorf L; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Martinistraße 52, N63, 20251, Hamburg, Germany.
Efremova EM; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Martinistraße 52, N63, 20251, Hamburg, Germany.
Holsten T; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Martinistraße 52, N63, 20251, Hamburg, Germany.; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Steinbügl M; Paediatric and Adolescent Medicine, Swabian Children's Cancer Center Augsburg, EU-RHAB Trial Center, Germany and Bavarian Cancer Research Center (BZKF), Augsburg, Germany.
Nemes K; Paediatric and Adolescent Medicine, Swabian Children's Cancer Center Augsburg, EU-RHAB Trial Center, Germany and Bavarian Cancer Research Center (BZKF), Augsburg, Germany.
Eckhardt A; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Martinistraße 52, N63, 20251, Hamburg, Germany.; Department of Radiotherapy and Radio-Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kresbach C; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Martinistraße 52, N63, 20251, Hamburg, Germany.; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bockmayr M; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Martinistraße 52, N63, 20251, Hamburg, Germany.; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Koch A; Institute of Neuropathology, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Haberler C; Institute of Neurology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Antonelli M; Department of Radiological, Oncological and Anatomic Pathology Sciences, Università Sapienza, Rome, Italy.
DeSisto J; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, CO, USA.
Schuhmann MU; Division of Pediatric Neurosurgery, Department of Neurosurgery, Eberhard Karl's University Hospital of Tübingen, Tübingen, Germany.
Hauser P; Second Department of Pediatrics, Semmelweis University, Budapest, Hungary.
Siebert R; Institute of Human Genetics, Ulm University & Ulm University Medical Center, Ulm, Germany.
Bens S; Institute of Human Genetics, Ulm University & Ulm University Medical Center, Ulm, Germany.
Kool M; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Research Consortium (DKTK), Heidelberg, Germany.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Green AL; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, CO, USA.; Department of Pediatrics, University of Colorado Denver, Aurora, CO, USA.
Hasselblatt M; Institute of Neuropathology, University Hospital Münster, Münster, Germany.
Frühwald MC; Paediatric and Adolescent Medicine, Swabian Children's Cancer Center Augsburg, EU-RHAB Trial Center, Germany and Bavarian Cancer Research Center (BZKF), Augsburg, Germany.
Schüller U; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. .; Research Institute Children's Cancer Center Hamburg, Martinistraße 52, N63, 20251, Hamburg, Germany. .; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. .
Pokaż więcej
Źródło:
Acta neuropathologica [Acta Neuropathol] 2023 Sep; Vol. 146 (3), pp. 527-541. Date of Electronic Publication: 2023 Jul 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Disease Progression*
DNA Copy Number Variations*/genetics
Epigenesis, Genetic*
Gene Expression Profiling*
Recurrence*
Rhabdoid Tumor*/classification
Rhabdoid Tumor*/genetics
Rhabdoid Tumor*/immunology
Rhabdoid Tumor*/pathology
Teratoma*/classification
Teratoma*/genetics
Teratoma*/immunology
Teratoma*/pathology
Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Chromosomes, Human, Pair 1/genetics ; Chromosomes, Human, Pair 10/genetics ; Cohort Studies ; Dendritic Cells ; DNA Methylation ; Histology ; Mitosis ; Sequence Analysis, RNA ; Transcription Factors/genetics ; Gene Expression Regulation, Neoplastic/genetics
SCR Disease Name:
Teratoid Tumor, Atypical
Czasopismo naukowe
Szczegóły
Tytuł:
Predicting the molecular mechanism-driven progression of breast cancer through comprehensive network pharmacology and molecular docking approach.
Autorzy:
Vyas B; School of Interdisciplinary Science and Technology, Jamia Hamdard, New Delhi, India.
Kumar S; ICAR-Indian Institute of Farming System Research, Modipuram, Meerut, 250110, India.
Bhowmik R; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
Akhter M; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 22; Vol. 13 (1), pp. 13729. Date of Electronic Publication: 2023 Aug 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Network Pharmacology*
Breast Neoplasms*/drug therapy
Breast Neoplasms*/metabolism
Molecular Docking Simulation*
Disease Progression*
Humans ; Biomarkers, Tumor ; Haplotypes ; Linkage Disequilibrium ; Endometriosis/drug therapy ; Polymorphism, Single Nucleotide ; Reproducibility of Results ; Drug Repositioning ; United States Food and Drug Administration/legislation & jurisprudence ; United States ; Drug Approval
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Non-cell-autonomous cancer progression from chromosomal instability.
Autorzy:
Li J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Hubisz MJ; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA.; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.; Bioinformatics Facility, Institute of Biotechnology, Cornell University, Ithaca, NY, USA.
Earlie EM; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA.; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Duran MA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Hong C; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Varela AA; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA.; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Lettera E; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Deyell M; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA.; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Tavora B; Volastra Therapeutics Inc., New York, NY, USA.
Havel JJ; Volastra Therapeutics Inc., New York, NY, USA.
Phyu SM; Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, UK.
Amin AD; Columbia Center for Translational Immunology, New York, NY, USA.; Division of Hematology and Oncology, Columbia University Medical Center, New York, NY, USA.
Budre K; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA.; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Kamiya E; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA.; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Cavallo JA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Garris C; Department of Pathology, Harvard Medical School, Boston, MA, USA.; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.
Powell S; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Reis-Filho JS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Wen H; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Bettigole S; Volastra Therapeutics Inc., New York, NY, USA.
Khan AJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Izar B; Columbia Center for Translational Immunology, New York, NY, USA.; Division of Hematology and Oncology, Columbia University Medical Center, New York, NY, USA.
Parkes EE; Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, UK.
Laughney AM; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA. .; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. .; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA. .
Bakhoum SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. .; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Aug; Vol. 620 (7976), pp. 1080-1088. Date of Electronic Publication: 2023 Aug 23.
Typ publikacji:
Journal Article
MeSH Terms:
Chromosomal Instability*
Disease Progression*
Neoplasms*/genetics
Neoplasms*/immunology
Neoplasms*/pathology
Humans ; Benchmarking ; Cell Communication ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/immunology ; Colorectal Neoplasms/pathology ; Melanoma/drug therapy ; Melanoma/genetics ; Melanoma/immunology ; Melanoma/pathology ; Tumor Microenvironment ; Interferon Type I/immunology ; Neoplasm Metastasis ; Endoplasmic Reticulum Stress ; Signal Transduction ; Triple Negative Breast Neoplasms/drug therapy ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/immunology ; Triple Negative Breast Neoplasms/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
The Role of Oxidative Stress in the Induction and Development of Psoriasis.
Autorzy:
Blagov A; Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
Sukhorukov V; Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
Guo S; Diabetes Research Center, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, 100029 Beijing, China.
Zhang D; Diabetes Research Center, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, 100029 Beijing, China.
Eremin I; Petrovsky National Research Centre of Surgery, 119991 Moscow, Russia.
Orekhov A; Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
Pokaż więcej
Źródło:
Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2023 Jun 25; Vol. 28 (6), pp. 118.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Psoriasis*/complications
Psoriasis*/drug therapy
Psoriasis*/immunology
Psoriasis*/metabolism
Oxidative Stress*
Disease Progression*
Humans ; Animals ; Antioxidants/therapeutic use ; Reactive Oxygen Species/metabolism ; Keratinocytes/metabolism ; Keratinocytes/pathology ; Autoimmune Diseases/complications ; Autoimmune Diseases/immunology ; Autoimmune Diseases/metabolism ; Autoimmune Diseases/pathology ; Inflammation/complications ; Inflammation/immunology ; Inflammation/metabolism ; Inflammation/pathology ; Biomarkers/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
The Role of Long Noncoding RNAs in Endometriosis Progression.
Autorzy:
Liu Y; Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100026 Beijing, China.
Zhang W; Beijing Shijitan Hospital, Capital Medical University, 100038 Beijing, China.
Jin L; Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100026 Beijing, China.
Ren J; Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100026 Beijing, China.
Liu Z; Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100026 Beijing, China.
Lu D; Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100026 Beijing, China.
Pokaż więcej
Źródło:
Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2023 Jun 08; Vol. 28 (6), pp. 109.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Endometriosis*/genetics
Endometriosis*/pathology
Endometriosis*/physiopathology
Disease Progression*
Exosomes/genetics ; Exosomes/metabolism ; RNA, Antisense/genetics ; RNA, Antisense/metabolism ; Hypoxia/genetics ; Humans ; Animals
Czasopismo naukowe
Szczegóły
Tytuł:
eIF3d: A driver of noncanonical cap-dependent translation of specific mRNAs and a trigger of biological/pathological processes.
Autorzy:
Ma S; Department of Cell and Cancer Biology, The University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
Liu JY; Department of Medicine, The University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
Zhang JT; Department of Cell and Cancer Biology, The University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA. Electronic address: .
Pokaż więcej
Źródło:
The Journal of biological chemistry [J Biol Chem] 2023 May; Vol. 299 (5), pp. 104658. Date of Electronic Publication: 2023 Mar 29.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms:
Eukaryotic Initiation Factor-3*/metabolism
Protein Biosynthesis*
RNA Caps*/metabolism
Disease Progression*
Humans ; COVID-19 ; Acquired Immunodeficiency Syndrome ; Carcinogenesis ; 5' Untranslated Regions/genetics
Czasopismo naukowe
Szczegóły
Tytuł:
Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus.
Autorzy:
Luebeck J; Department of Computer Science and Engineering, University of California at San Diego, La Jolla, CA, USA.; Bioinformatics and Systems Biology Graduate Program, University of California at San Diego, La Jolla, CA, USA.
Ng AWT; Early Cancer Institute, Hutchison Research Centre, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Galipeau PC; Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Li X; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Sanchez CA; Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Katz-Summercorn AC; Early Cancer Institute, Hutchison Research Centre, University of Cambridge, Cambridge, UK.
Kim H; Department of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, Republic of Korea.; Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, Republic of Korea.
Jammula S; Early Cancer Institute, Hutchison Research Centre, University of Cambridge, Cambridge, UK.
He Y; Moores Cancer Center, UC San Diego Health, La Jolla, CA, USA.; Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.; Department of Bioengineering, University of California at San Diego, La Jolla, CA, USA.
Lippman SM; Moores Cancer Center, UC San Diego Health, La Jolla, CA, USA.
Verhaak RGW; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Maley CC; Biodesign Institute, Arizona State University, Tempe, AZ, USA.
Alexandrov LB; Moores Cancer Center, UC San Diego Health, La Jolla, CA, USA.; Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.; Department of Bioengineering, University of California at San Diego, La Jolla, CA, USA.
Reid BJ; Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.
Fitzgerald RC; Early Cancer Institute, Hutchison Research Centre, University of Cambridge, Cambridge, UK. .
Paulson TG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. .
Chang HY; Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA, USA. .; Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA. .
Wu S; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA. .
Bafna V; Department of Computer Science and Engineering, University of California at San Diego, La Jolla, CA, USA. .; Halıcıoğlu Data Science Institute, University of California at San Diego, La Jolla, CA, USA. .
Mischel PS; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. .; Sarafan Chemistry, Engineering, and Medicine for Human Health (Sarafan ChEM-H), Stanford University, Stanford, CA, USA. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Apr; Vol. 616 (7958), pp. 798-805. Date of Electronic Publication: 2023 Apr 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Barrett Esophagus*/genetics
Barrett Esophagus*/pathology
DNA*/genetics
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/pathology
Carcinogenesis*/genetics
Disease Progression*
Early Detection of Cancer*/methods
Humans ; Case-Control Studies ; Whole Genome Sequencing ; Cohort Studies ; Biopsy ; Oncogenes ; Immunomodulation ; DNA Copy Number Variations ; Gene Amplification
Czasopismo naukowe
Szczegóły
Tytuł:
[Postpolio Syndrome - One of the Late Effects of Polyomyelitis].
Autorzy:
Anastasopoulos D; Neurorehabilitation, ZURZACH Care, Bad Zurzach, Schweiz.
Pokaż więcej
Transliterated Title:
Postpolio-Syndrom – eine der Spätfolgen der Polyomyelitis.
Źródło:
Praxis [Praxis (Bern 1994)] 2023 Feb; Vol. 112 (2), pp. 55-56.
Typ publikacji:
Editorial
MeSH Terms:
Disease Progression*
Poliomyelitis*/complications
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of potential pathways and biomarkers linked to progression in ALS.
Autorzy:
Huber RG; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Matrix #07-01, 30 Biopolis Street, Singapore, 138671, Singapore.
Pandey S; Department of Neurology, McKnight Brain Institute, and Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, 32611, USA.
Chhangani D; Department of Neurology, McKnight Brain Institute, and Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, 32611, USA.
Rincon-Limas DE; Department of Neurology, McKnight Brain Institute, and Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, 32611, USA.
Staff NP; Department of Neurology, Mayo Clinic, Rochester, Minnesota, 55905, USA.
Yeo CJJ; Agency for Science, Technology and Research (A*STAR), IMCB, 61 Biopolis Drive, Proteos, Singapore, 138673, Singapore.; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, 60611, USA.; Lee Kong Chian School of Medicine, Imperial College London and NTU Singapore, Singapore, 308232, Singapore.; School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, AB243FX, Scotland, UK.; National Neuroscience Institute, TTSH Campus, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore.; Duke NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2023 Feb; Vol. 10 (2), pp. 150-165. Date of Electronic Publication: 2022 Dec 19.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Amyotrophic Lateral Sclerosis*/diagnosis
Amyotrophic Lateral Sclerosis*/drug therapy
Disease Progression*
Proteomics*/methods
Humans ; Biomarkers ; Motor Neurons/metabolism ; Motor Neurons/pathology ; Phenotype ; Machine Learning ; Disease Models, Animal ; Drosophila/genetics ; Drosophila/metabolism ; Induced Pluripotent Stem Cells/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Disease progression promotes changes in adipose tissue signatures in type 2 diabetic (db/db) mice: The potential pathophysiological role of batokines.
Autorzy:
Ziqubu K; Department of Biochemistry, North-West University, Mmabatho 2745, South Africa.
Dludla PV; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa; Department of Biochemistry and Microbiology, Faculty of Science and Agriculture, University of Zululand, KwaDlangezwa 3886, South Africa.
Moetlediwa MT; Department of Biochemistry, North-West University, Mmabatho 2745, South Africa; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa.
Nyawo TA; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa; Centre for Cardio-Metabolic Research in Africa, Division of Medical Physiology, University of Stellenbosch, Tygerberg 7505, South Africa.
Pheiffer C; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa; Centre for Cardio-Metabolic Research in Africa, Division of Medical Physiology, University of Stellenbosch, Tygerberg 7505, South Africa; Department of Obstetrics and Gynaecology, Faculty of Health Science, University of Pretoria, Pretoria 0001, South Africa.
Jack BU; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa.
Nkambule B; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.
Mazibuko-Mbeje SE; Department of Biochemistry, North-West University, Mmabatho 2745, South Africa. Electronic address: .
Pokaż więcej
Źródło:
Life sciences [Life Sci] 2023 Jan 15; Vol. 313, pp. 121273. Date of Electronic Publication: 2022 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Adipose Tissue, Brown*/metabolism
Adipose Tissue, Brown*/pathology
Diabetes Mellitus, Type 2*/metabolism
Diabetes Mellitus, Type 2*/pathology
Disease Progression*
Animals ; Mice ; Adiponectin/metabolism ; Adipose Tissue/metabolism ; Adipose Tissue, White/metabolism ; Mice, Inbred C57BL ; Thermogenesis
Czasopismo naukowe
Szczegóły
Tytuł:
Predictors of decline in kidney function in the general population: a decade of follow-up from the Tehran Lipid and Glucose Study.
Autorzy:
Masrouri S; Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Alijanzadeh D; Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Amiri M; Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Azizi F; Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hadaegh F; Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Annals of medicine [Ann Med] 2023 Dec; Vol. 55 (1), pp. 2216020.
Typ publikacji:
Journal Article
MeSH Terms:
Renal Insufficiency, Chronic*/complications
Hypertension*/complications
Diabetes Mellitus*/epidemiology
Cardiovascular Diseases*/complications
Humans ; Female ; Cohort Studies ; Follow-Up Studies ; Glucose ; Iran/epidemiology ; Kidney ; Glomerular Filtration Rate ; Risk Factors ; Lipids ; Disease Progression
Czasopismo naukowe
Szczegóły
Tytuł:
Association of Mediterranean Diet Adherence with Disease Progression Characteristics, Lifestyle Factors and Overall Survival in Gastric Cancer Patients.
Autorzy:
Pavlidou E; Department of Food Science and Nutrition, School of the Environment, University of the Aegean, 81400 Lemnos, Greece.
Papadopoulou SK; Department of Nutritional Sciences and Dietetics, Faculty of Health Sciences, International Hellenic University, 57400 Thessaloniki, Greece.
Tolia M; Department of Radiotherapy, Faculty of Medicine, School of Health Sciences, University of Crete, 71003 Heraklion, Crete, Greece.
Mentzelou M; Department of Food Science and Nutrition, School of the Environment, University of the Aegean, 81400 Lemnos, Greece.
Tsoukalas N; Department of Oncology, 401 General Army Hospital of Athens, 401 Geniko Stratiotiko Nosokomeio, 11525 Athens, Greece.
Alexatou O; Department of Food Science and Nutrition, School of the Environment, University of the Aegean, 81400 Lemnos, Greece.
Tsiouda T; Oncology Department, 'Theageneio' Anticancer Hospital, 54639 Thessaloniki, Greece.
Tsourouflis G; Second Department of Propedeutic Surgery, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Psara E; Department of Food Science and Nutrition, School of the Environment, University of the Aegean, 81400 Lemnos, Greece.
Bikos V; Oncology Department, 'Theageneio' Anticancer Hospital, 54639 Thessaloniki, Greece.
Kavantzas N; First Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Athens General Hospital 'Laikon', 11527 Athens, Greece.
Kotta-Loizou I; Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, South Kensington Campus, London SW7 2AZ, UK.
Dakanalis A; Department of Mental Health, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.; School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Vorvolakos T; Department of Psychiatry, School of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Giaginis C; Department of Food Science and Nutrition, School of the Environment, University of the Aegean, 81400 Lemnos, Greece.
Pokaż więcej
Źródło:
Medical sciences (Basel, Switzerland) [Med Sci (Basel)] 2023 Nov 15; Vol. 11 (4). Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Diet, Mediterranean*
Stomach Neoplasms*
Carcinoma*
Humans ; Quality of Life ; Smoking ; Life Style ; Disease Progression
Czasopismo naukowe
Szczegóły
Tytuł:
Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson's disease: a prospective cohort study.
Autorzy:
Lin J; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Ou R; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Li C; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Hou Y; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Zhang L; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Wei Q; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Pang D; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Liu K; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Jiang Q; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Yang T; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Xiao Y; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Zhao B; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Chen X; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Song W; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Yang J; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Wu Y; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Shang H; Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2023 Nov 06; Vol. 21 (1), pp. 420. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Parkinson Disease*/complications
Humans ; Activities of Daily Living ; Biomarkers ; Disease Progression ; Glial Fibrillary Acidic Protein ; Intermediate Filaments ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
MiR-155 Negatively Regulates Anti-Viral Innate Responses among HIV-Infected Progressors.
Autorzy:
Pawar P; Division of Immunology and Serology, ICMR-National AIDS Research Institute, Pune 411026, India.
Gokavi J; Division of Immunology and Serology, ICMR-National AIDS Research Institute, Pune 411026, India.
Wakhare S; Division of Immunology and Serology, ICMR-National AIDS Research Institute, Pune 411026, India.
Bagul R; Division of Clinical Sciences, ICMR-National AIDS Research Institute, Pune 411026, India.
Ghule U; Division of Clinical Sciences, ICMR-National AIDS Research Institute, Pune 411026, India.
Khan I; Division of Virology, ICMR-National AIDS Research Institute, Pune 411026, India.
Ganu V; Division of Immunology and Serology, ICMR-National AIDS Research Institute, Pune 411026, India.
Mukherjee A; Division of Virology, ICMR-National AIDS Research Institute, Pune 411026, India.
Shete A; Division of Immunology and Serology, ICMR-National AIDS Research Institute, Pune 411026, India.
Rao A; Division of Clinical Sciences, ICMR-National AIDS Research Institute, Pune 411026, India.
Saxena V; Division of Immunology and Serology, ICMR-National AIDS Research Institute, Pune 411026, India.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Nov 01; Vol. 15 (11). Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
MicroRNAs*/genetics
MicroRNAs*/therapeutic use
Humans ; Toll-Like Receptor 7 ; Toll-Like Receptor 3/metabolism ; Cytokines/metabolism ; Immunity, Innate ; Disease Progression ; Antiviral Agents/therapeutic use ; Membrane Proteins/metabolism ; RNA-Binding Proteins
Czasopismo naukowe
Szczegóły
Tytuł:
Longitudinal Characterization of the Clinical Course of Intermediate-Severe Salla Disease.
Autorzy:
Chapleau A; Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montréal, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
Mirchi A; Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montréal, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada; Department of Pediatrics, McGill University, Montréal, Canada.
Tran LT; Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montréal, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
Poulin C; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada; Department of Pediatrics, McGill University, Montréal, Canada.
Bernard G; Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montréal, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada; Department of Pediatrics, McGill University, Montréal, Canada; Department of Human Genetics, McGill University, Montréal, Canada; Division of Medical Genetics, Department of Specialized Medicine, McGill University Health Centre, Montréal, Canada. Electronic address: .
Pokaż więcej
Źródło:
Pediatric neurology [Pediatr Neurol] 2023 Nov; Vol. 148, pp. 133-137. Date of Electronic Publication: 2023 Aug 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Sialic Acid Storage Disease*/genetics
Adolescent ; Humans ; Child ; Child, Preschool ; Mutation/genetics ; N-Acetylneuraminic Acid ; Disease Progression
SCR Disease Name:
Free sialic acid storage disease
Czasopismo naukowe
Szczegóły
Tytuł:
Exploring the Validity of GOLD 2023 Guidelines: Should GOLD C and D Be Combined?
Autorzy:
Duckworth C; IT Innovation Centre, Digital Health and Biomedical Engineering, University of Southampton, Southampton, UK.
Boniface MJ; IT Innovation Centre, Digital Health and Biomedical Engineering, University of Southampton, Southampton, UK.
Kirk A; My mHealth Limited, London, UK.
Wilkinson TMA; My mHealth Limited, London, UK.; National Institute for Health Research Biomedical Research Centre, University of Southampton, Southampton, UK.; Faculty of Medicine, University of Southampton, Southampton, UK.
Pokaż więcej
Źródło:
International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2023 Oct 24; Vol. 18, pp. 2335-2339. Date of Electronic Publication: 2023 Oct 24 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Disease, Chronic Obstructive*/diagnosis
Asthma*
Humans ; Forced Expiratory Volume ; Severity of Illness Index ; Disease Progression
SCR Disease Name:
Pulmonary Disease, Chronic Obstructive, Severe Early-Onset
Czasopismo naukowe
Szczegóły
Tytuł:
How immune breakthroughs could slow disease progression and improve prognosis in COVID-19 patients: a retrospective study.
Autorzy:
Wang Y; School of Public Health, Chengdu Medical College, Chengdu, China.
Zhao B; The First Ward of Internal Medicine, Public Health Clinic Centre of Chengdu, Chengdu, China.
Zhang X; Department of Endocrinology & Metabolism, Sichuan University West China Hospital, Chengdu, China.
Zhang X; The First Ward of Internal Medicine, Public Health Clinic Centre of Chengdu, Chengdu, China.
Gao F; The First Ward of Internal Medicine, Public Health Clinic Centre of Chengdu, Chengdu, China.
Yuan X; The First Ward of Internal Medicine, Public Health Clinic Centre of Chengdu, Chengdu, China.
Ren X; The First Ward of Internal Medicine, Public Health Clinic Centre of Chengdu, Chengdu, China.
Li M; School of Public Health, Chengdu Medical College, Chengdu, China.
Liu D; The First Ward of Internal Medicine, Public Health Clinic Centre of Chengdu, Chengdu, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Oct 23; Vol. 14, pp. 1246751. Date of Electronic Publication: 2023 Oct 23 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
Humans ; Retrospective Studies ; SARS-CoV-2 ; Prognosis ; Disease Progression ; Immunoglobulin G
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 179263

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies